GNLKQ

GeneLink, Inc. GNLKQ

GNLKQ
GeneLink, Inc. TRVN
Trevena, Inc. EHOS
Ehouse Global, Inc. NAVB
Navidea Biopharmaceuticals, Inc. NNLX
NanoLogix, Inc. ARDS
Aridis Pharmaceuticals, Inc. RCAR
RenovaCare, Inc. INFIQ
Infinity Pharmaceuticals, Inc. HLTT
Healthtech Solutions Inc. PXMD
PaxMedica, Inc. Common Stock

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode GNLKQ TRVN EHOS NAVB NNLX ARDS RCAR INFIQ HLTT PXMD
6M -60.00 % -98.92 % 0.00 % -83.33 % 0.00 % 100.00 % 0.00 % 900.00 % 0.00 % 0.00 %
YTD -60.00 % -99.25 % 900.00 % 0.00 % 0.00 % 100.00 % 0.00 % 900.00 % 0.00 % -99.85 %
1Y -60.00 % -99.44 % 900.00 % -80.00 % 900.00 % 100.00 % 0.00 % 0.00 % 0.00 % -99.92 %
3Y -60.00 % -99.99 % -90.00 % -99.96 % -50.00 % -99.98 % -99.81 % -99.99 % -99.98 % -100.00 %
5Y -94.29 % -100.00 % 99 900.00 % -100.00 % -99.82 % -100.00 % -100.00 % -99.99 % -99.86 % -100.00 %
10Y -86.67 % -100.00 % -99.90 % -100.00 % -99.60 % -100.00 % -99.99 % -100.00 % -94.44 % -100.00 %
From the beginning -100.00 % -100.00 % -66.67 % -100.00 % -99.97 % -100.00 % -99.99 % -100.00 % -99.99 % -100.00 %

Dividend